Upstream Processing: Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies - An alternative to the hybridoma method is producing engineered antibody molecules and fragments

ADVERTISEMENT

Upstream Processing: Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies
An alternative to the hybridoma method is producing engineered antibody molecules and fragments by in vitro methods.


BioPharm International
Volume 20, Issue 7

35. http:// http://www.emea.eu.int/humandocs/Humans/EPAR/synagis/Synagis.htm [Accessed 2005 Oct 15].

36. http:// http://www.ebra.org/ebrabulletin-ecvam-report-monoclonal-antibody-production_76.htm [Accessed 2005 Sept 22].

37. http:// http://www.emea.info/humandocs/Humans/EPAR/leukoscan/leukoscan.htm; [Accessed 2005 Sept 23].

38. http:// http://www.emea.info/humandocs/PDFs/EPAR/Ceascan/041296en6.pdf; [Accessed 2005 Sept 22].

39. Marx U, Embleton MJ, Fischer R. Monoclonal antibody production. The report and recommendations of ECVAM workshop 23. 1997 ATLA 25:121-135.

40. Werner RG. The development and production of biopharmaceuticals. Bioprocess International 2005 Supplement to Vol. 3; 9:6-15.

41. http:// http://www.emea.eu.int/humandocs/Humans/EPAR/enbrel/enbrel.htm [Accessed 2005 Oct 11].

42. http:// http://www.emea.eu.int/humandocs/Humans/EPAR/humira/humira.htm; [Accessed 2005 Oct 14].

43. http:// http://www.emea.eu.int/humandocs/Humans/EPAR/herceptin/herceptin.htm; [Accessed 2005 Oct 15]

44. http:// http://www.preclinica.com/content/articles/frame.asp?issue=0304&article=12; [Accessed 2006, Oct 12]


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

AbbVie/Shire Deal Officially Off
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Lilly to Close Manufacturing Facility in Puerto Rico
October 17, 2014
BioReliance Introduces New Predictive Assays
October 17, 2014
Author Guidelines
Source: BioPharm International,
Click here